NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.03
+0.21 (1.18%)
Nov 4, 2024, 4:00 PM EST - Market closed
NAMS Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for NAMS stock have an average target of 33.8, with a low estimate of 30 and a high estimate of 37. The average target predicts an increase of 87.47% from the current stock price of 18.03.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 23, 2024.
Analyst Ratings
The average analyst rating for NAMS stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $37 | Buy | Reiterates | $37 | +105.21% | Sep 23, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +71.94% | Sep 5, 2024 |
| Needham | Needham | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +99.67% | Aug 28, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +71.94% | Jul 30, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +71.94% | Jun 7, 2024 |
Financial Forecast
Revenue This Year
11.16M
from 14.09M
Decreased by -20.83%
Revenue Next Year
6.49M
from 11.16M
Decreased by -41.81%
EPS This Year
-2.49
from -2.15
EPS Next Year
-1.77
from -2.49
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 30.1M | 38.5M | 61.2M | ||
| Avg | 11.2M | 6.5M | 15.7M | ||
| Low | 3.6M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 113.7% | 245.2% | 842.3% | ||
| Avg | -20.8% | -41.8% | 142.2% | ||
| Low | -74.4% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.35 | -1.17 | -1.10 | ||
| Avg | -2.49 | -1.77 | -1.70 | ||
| Low | -2.55 | -2.26 | -2.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.